| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/28/2002 | WO2002015700A1 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 02/28/2002 | WO2002009667A9 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/28/2002 | WO2002000269A8 The use of honey in wound dressings |
| 02/28/2002 | WO2001093853B1 Management of snoring by oral administration of dimethyl sulfone |
| 02/28/2002 | WO2001085699A3 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/28/2002 | WO2001083385A3 Devices and method for production of traceable immunizing drinking water, other liquids and gas |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001076636A3 Pharmaceutical composition of modified pna molecules |
| 02/28/2002 | WO2001072281A3 Microspheres for active embolization |
| 02/28/2002 | WO2001066084A3 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 02/28/2002 | WO2001064254A3 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 02/28/2002 | WO2001062217A3 Oil-based cosmetics containing water-soluble actives |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001045661A3 Cosmetic and/or pharmaceutical preparations |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001041776B1 Use of honey in medical dressings |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001036656B1 A complex between hyaluronic acid and a biomolecule and its use |
| 02/28/2002 | WO2001032851A3 Modular transport systems for molecular substances and production and use thereof |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | WO2001024804A3 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | US20020026236 Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia |
| 02/28/2002 | US20020025984 Tablets, capsules |
| 02/28/2002 | US20020025981 Synergistic mixture of amlodipine and statins |
| 02/28/2002 | US20020025979 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/28/2002 | US20020025953 Using oil |
| 02/28/2002 | US20020025946 Acylated cyclodextrin: guest molecule inclusion complexes |
| 02/28/2002 | US20020025941 Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal |
| 02/28/2002 | US20020025927 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/28/2002 | US20020025920 Novel lipid complexes for transferring at least one therapeutically active substance, in particular a polynucleotide, into a target cell, and use in gene therapy |
| 02/28/2002 | US20020025578 Intensified expression of nucleotide sequences in mammal; administer nucleic acids to mammal, transfect nucleotide sequence using voltage, monitor mammal for gene expression |
| 02/28/2002 | US20020025539 Complexing in solvent |
| 02/28/2002 | US20020025344 As antimicrobial agent |
| 02/28/2002 | US20020025342 Novel administration form comprising an acid-labile active compound |
| 02/28/2002 | US20020025338 Bioavailable dosage form of isotrentinoin |
| 02/28/2002 | US20020025337 Lipid vehicle drug delivery composition containing vitamin e |
| 02/28/2002 | US20020025333 Composition comprising a hydrophilic component and a combination of a volatile compound and a pasty fatty compound, and use thereof |
| 02/28/2002 | US20020025313 Targeting of liposomes to the blood-brain barrier |
| 02/28/2002 | US20020025312 Bifunctional water-soluble polymer derivative and complex containing it |
| 02/28/2002 | US20020025299 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 02/28/2002 | DE10040174A1 Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
| 02/28/2002 | DE10040105A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften Peptide and peptidomimetic derivatives having integrin inhibitor properties |
| 02/28/2002 | CA2678754A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | CA2420198A1 Calycins |
| 02/28/2002 | CA2420194A1 Use of a porous carrier |
| 02/28/2002 | CA2420193A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420190A1 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2420176A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2419597A1 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading |
| 02/28/2002 | CA2419592A1 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2419454A1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | CA2418730A1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2416748A1 Improved specificity in treatment of diseases |
| 02/28/2002 | CA2415349A1 Testosterone ester formulation for human use |
| 02/28/2002 | CA2356124A1 Anti-ige vaccines |
| 02/27/2002 | EP1182208A2 Composition for DNA transfection |
| 02/27/2002 | EP1181983A2 Spray gun for enteric coating and process for producing enteric coated preparation |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181937A2 Novel vaccine adjuvant and vaccine |
| 02/27/2002 | EP1181377A2 Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181329A1 Silicone gel containing salicylic acid |
| 02/27/2002 | EP1181323A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181055A2 Enzyme-activated anti-tumor prodrug compounds |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181044A2 IMMOBILIZED LACTOFERRIN ( i Im /i -LF) ANTIMICROBIAL AGENTS AND USES THEREOF |
| 02/27/2002 | EP1181040A1 Compositions of a-beta peptide and processes for producing same |
| 02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/27/2002 | EP1181036A1 Pharmaceutical compositions of erythropoietin |
| 02/27/2002 | EP1181035A2 Substantially oil-free cyclosporin compositions |
| 02/27/2002 | EP1181029A1 Balsam for the treatment of surface burns and chafing rashes |
| 02/27/2002 | EP1181023A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| 02/27/2002 | EP1181018A1 Ziprasidone suspension |
| 02/27/2002 | EP1181010A1 Pharmaceutical chewing gum formulations |
| 02/27/2002 | EP1181001A2 Sunscreen composition containing sol-gel microcapsules |
| 02/27/2002 | EP1003559B1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/27/2002 | EP0946156B1 Drinkable ibuprofen composition |
| 02/27/2002 | EP0939623B1 Oral delayed immediate release formulation and method of preparation therefor |
| 02/27/2002 | EP0917460B1 Cyclosporin formulation |
| 02/27/2002 | EP0914127B1 Antifungal composition with enhanced bioavailability |
| 02/27/2002 | EP0868172B1 Direct compression carbonyl iron tablet |
| 02/27/2002 | EP0859634B1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 02/27/2002 | EP0830144B1 Water soluble, powder form compositions and applications thereof |
| 02/27/2002 | EP0797441B1 Pharmaceutical composition comprising lamotrigine |
| 02/27/2002 | EP0794802B1 Inclusion complex of a radiohalogenated fatty acid in a cyclodextrin |
| 02/27/2002 | EP0784466B1 Use and composition of an anti-sexually transmitted diseases formulation |
| 02/27/2002 | CN1337882A Pharmaceutical composition for the treatment o f rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 02/27/2002 | CN1337878A Methods for treating overian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 02/27/2002 | CN1337877A Method of preparing stable suspension of insoluble microparticles |
| 02/27/2002 | CN1337876A Fast dispersing dosage forms free of gelatin |
| 02/27/2002 | CN1337225A Transdermal physiotherapeutic medicine gel |
| 02/27/2002 | CN1079677C Immunological tolerance-inducting agent |